Studies over the past several decades have found that the expression profiles of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (Her2)/neu are closely related with breast cancer, and have been used for predicting the outcome and response to breast cancer therapy[3,4]. The gene discussed is ESR1; the disease is breast carcinoma.